Skip to contentC
ClearPoint Neuro, Inc.
C
CLPTClearPoint Neuro, Inc. Q2 2023 · 10-Q
Revenue$5.95M$5.95M+14.4% vs Q2 2022 Net Income-$7.05M-$7.05MN/M vs Q2 2022 EPS Diluted-$0.29-$0.29N/M vs Q2 2022 Gross Profit$3,126,000−4.0% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ClearPoint Neuro, Inc. · CIK 1285550 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,075,000N/M Free Cash Flowderived-$5,398,000N/M Margins · derivedGross margin52.5%−10.1 pt vs Q2 2022
Operating margin-119.8%−39.0 pt vs Q2 2022
Net margin-118.5%−35.8 pt vs Q2 2022
ended Jun 30, 2023 · filed Aug 8, 2023 · 39 d after period end